(Q44811677)

6 December 2017

title

A five-gene model predicts clinical outcome in ER+/PR+, early-stage breast cancers treated with adjuvant tamoxifen (English)

1 reference

6 December 2017

1 reference

Daniel Alan Kerr

1

1 reference

6 December 2017

James L Wittliff

series ordinal

2

1 reference

6 December 2017

publication date

1 October 2011

1 reference

6 December 2017

1 reference

6 December 2017

volume

2

1 reference

6 December 2017

issue

5

1 reference

6 December 2017

page(s)

261-271

1 reference

https://scigraph.springernature.com/pub.10.1007/s12672-011-0080-8

6 December 2017

exact match

0 references

cites work

A 2009 update on the treatment of patients with hormone receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates with response to tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

Predictive markers in breast cancer--the present

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

Progesterone receptors and human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

Development of the 21-gene assay and its application in clinical practice and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

A candidate molecular signature associated with tamoxifen failure in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

Perioperative screening for metastatic disease is not indicated in patients with primary breast cancer and no clinical signs of tumor spread.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

Laser capture microdissection and its applications in genomics and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

ERTargetDB: an integral information resource of transcription regulation of estrogen receptor target genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

The RIN: an RNA integrity number for assigning integrity values to RNA measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL-2 than tamoxifen in MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

The CD34 Antigen: Structure, Biology, and Potential Clinical Applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

Genome-wide identification of high-affinity estrogen response elements in human and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-011-0080-8

Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

21 January 2018

1 reference

12 December 2020

Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens

1 reference

12 December 2020

Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer

1 reference

12 December 2020

Steroid-hormone receptors in breast cancer

1 reference

12 December 2020

Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index

1 reference

12 December 2020

Duration of adjuvant tamoxifen therapy.

1 reference

12 December 2020

Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer

1 reference

12 December 2020

Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination

1 reference

12 December 2020

Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study

1 reference

12 December 2020

Treatment of primary breast cancer with chemotherapy and tamoxifen

1 reference

12 December 2020

Special report. Steriod receptors in breast cancer

1 reference

12 December 2020

Reporting recommendations for tumor marker prognostic studies

1 reference

12 December 2020

10.1007/S12672-011-0080-8

Identifiers

DOI

1 reference

6 December 2017

1 reference